Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFX
426
DELISTED
Newfield Exploration
NFX
| $21.4M | 0.06% |
+897,200
| New | +$20.5M |
|
427
Labcorp
LH
$24.5B
| $21.4M | 0.06% |
+249,013
| New | +$20.7M |
|
428
Gold Fields
GFI
$29.4B
| $21.4M | 0.06% |
+4,072,100
| New | +$26M |
|
|
CNL
429
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $21.3M | 0.06% |
+458,700
| New | +$21.4M |
|
|
HNT
430
DELISTED
HEALTH NET INC
HNT
| $21.2M | 0.06% |
+667,400
| New | +$20.1M |
|
|
AXON
431
Axon Enterprise
AXON
$42.4B
| $21.1M | 0.06% |
+2,478,352
| New | +$21.7M |
|
432
NVIDIA
NVDA
$4.76T
| $20.9M | 0.05% |
+59,503,720
| New | +$20.5M |
|
433
Ryder
R
$10.2B
| $20.9M | 0.05% |
+343,400
| New | +$20.7M |
|
|
SPR
434
DELISTED
Spirit AeroSystems
SPR
| $20.9M | 0.05% |
+970,800
| New | +$20.1M |
|
435
Old Republic International
ORI
$10.5B
| $20.8M | 0.05% |
+1,617,685
| New | +$21.4M |
|
|
WWE
436
DELISTED
World Wrestling Entertainment
WWE
| $20.8M | 0.05% |
+2,018,200
| New | +$18.9M |
|
437
ITT
ITT
$17.3B
| $20.8M | 0.05% |
+706,800
| New | +$20.3M |
|
|
SVM
438
Silvercorp Metals
SVM
$2.15B
| $20.8M | 0.05% |
+7,360,200
| New | +$21.3M |
|
|
RJET
439
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $20.6M | 0.05% |
+1,820,700
| New | +$19.6M |
|
440
Spok Holdings
SPOK
$227M
| $20.6M | 0.05% |
+1,520,100
| New | +$20.2M |
|
|
SRCL
441
DELISTED
Stericycle Inc
SRCL
| $20.6M | 0.05% |
+186,720
| New | +$20.3M |
|
|
ASEI
442
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $20.6M | 0.05% |
+367,411
| New | +$22.2M |
|
443
First Horizon
FHN
$12.1B
| $20.5M | 0.05% |
+1,828,282
| New | +$19.8M |
|
|
ARRS
444
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $20.3M | 0.05% |
+1,417,220
| New | +$22.4M |
|
|
CHG
445
DELISTED
CH ENERGY GRP INC(HOLDING CO)
CHG
| $20.3M | 0.05% |
+312,600
| New | +$20.3M |
|
|
VG
446
DELISTED
Vonage Holdings Corporation
VG
| $20.3M | 0.05% |
+7,173,119
| New | +$20.4M |
|
447
SITE Centers
SITC
$234M
| $20.3M | 0.05% |
+944,056
| New | +$21.8M |
|
|
LGF
448
DELISTED
Lions Gate Entertainment
LGF
| $20.1M | 0.05% |
+730,500
| New | +$19.1M |
|
449
J&J Snack Foods
JJSF
$1.46B
| $20M | 0.05% |
+256,800
| New | +$19.5M |
|
|
OCR
450
DELISTED
OMNICARE INC
OCR
| $19.9M | 0.05% |
+417,200
| New | +$18.7M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.